Everas test results: Tested. Not just promised. Independent testing. Results you can see.
Everas / Quality & transparencyFinished capsules + ingredient analysis

What is in our capsules?
Here is the measured amount.

A labeled 500 mg serving. A laboratory result you can inspect. See the finished-capsule potency result alongside the separate ingredient-purity analysis.

Finished capsules / Urolithin A
505.810 mg

Per serving of 2 capsules · Lot EVR-2608-001

Meets the reported specification

The finished serving, measured by HPLC.

Summit Nutritional Laboratories reported 505.810 mg per serving against a specification of >500 mg. Results apply to the submitted sample.

Finished-capsule certificate of analysis

Read the complete capsule test report

505.810 mg per two-capsule serving · Lot EVR-2608-001
Summit Nutritional Laboratories · September 21, 2026 · PDF

View capsule test report (PDF) ↗
01 /

Finished-capsule potency

Everas Urolithin A Capsules · Lot EVR-2608-001
AnalyteMethodSpecificationResultUnits
Urolithin AHPLC>500505.810mg/serving

The report lists a serving size of 2.000 capsules. This is a measured result for the identified lot, not a promise of the exact amount in every individual capsule.

02 /

Trace the result to its report

Testing laboratory
Summit Nutritional Laboratories
Report number
260915 030-02.168
Customer on report
Everas
Product / description
Everas Urolithin A Capsules
Lot number
EVR-2608-001
Serving size
2.000 capsules
Sample received
September 15, 2026
Testing dates
September 15–21, 2026
Report issued
September 21, 2026
Approved by
Joel L. Nelson, Laboratory Director
03 /

Purity and potency answer different questions

Potency: how much is in a serving?

The capsule report measures Urolithin A in mg per two-capsule serving. Its result is 505.810 mg. The report’s separate 280.00 mg average net fill weight is not the Urolithin A result.

Purity: what is the ingredient concentration?

The earlier ingredient report measured 99.733 g per 100 g of its sample, or 99.733% by weight. It concerns ingredient lot 20260313; it does not measure the percentage of Urolithin A in a finished capsule.

Separate ingredient report
99.733% by weight

HPLC · Lot 20260313 · Report 260812 026-03 · Issued August 20, 2026

Read ingredient report ↗
04 /

What these results establish

Specific samples. Specific measurements.

These reports provide the stated Urolithin A results for the submitted samples. They do not establish a clinical benefit, an individual safety outcome, or equivalence to another brand’s formulation.

Other testing has a separate scope.

Everas has separately reported ND results for microbial and heavy-metal testing. Neither Urolithin A report displayed here includes those panels. ND means not detected at the applicable laboratory limit, not absolute zero.

Laboratory accreditation information

The reports list ISO/IEC 17025:2017 and PJLA accreditation number 75696. The laboratory uses a ¥ symbol to identify accredited analyses; the Urolithin A rows are not marked with that symbol. Laboratory accreditation is not product certification.

A transparent daily routine.

500 mg labeled serving · Two capsules · 30 servings per pouch

Explore Everas capsules ↗